SPONSOR
Fujian Medical University
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Aortic Dissection Type AAdvanced Hepatocellular CarcinomaOverall Response RateGastric Cancer
Fujian Medical University is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Aortic Dissection Type A, Advanced Hepatocellular Carcinoma, Overall Response Rate, Gastric Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fujian Medical University
How many clinical trials has Fujian Medical University sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Fujian Medical University, of which 4 are actively recruiting participants. These trials cover conditions including Aortic Dissection Type A, Advanced Hepatocellular Carcinoma, Overall Response Rate. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fujian Medical University research focus on?
Fujian Medical University clinical trials span Aortic Dissection Type A, Advanced Hepatocellular Carcinoma, Overall Response Rate, Gastric Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fujian Medical University clinical trial?
To participate in a Fujian Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fujian Medical University trials with current recruitment status updated daily.
Clinical Trials by Fujian Medical University
NCT07383909
Recruiting
Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery
Aortic Dissection Type A
NCT06363825 Phase 2
Recruiting
A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
NCT06277024
Recruiting
A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients
Overall Response Rate
NCT05618821 Phase 2
Recruiting
Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer
Gastric Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology